Cell Therapy Market Performance and Future Outlook at 14.2% CAGR Through 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Cell Therapy Industry By 2029?

The cell therapy market has experienced substantial growth in its size during recent years. This market is projected to expand from $14.56 billion in 2024 to $16.87 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.8%. Historically, the expansion of the market can be attributed to initial research and discoveries, critical regulatory milestones, comprehensive clinical trials and studies, the involvement of early adopters and pioneering companies, and broader market acceptance and perception.

The cell therapy market is anticipated to experience substantial growth over the next few years, expanding to $28.67 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 14.2%. This expected expansion during the forecast period is fueled by ethical and societal factors, investment and funding patterns, consumer/patient requirements, advancements in healthcare infrastructure, and swift innovation cycles. Significant trends in the coming period involve personalized medicine, novel targeted treatments, gene editing technologies, the expansion of stem cell research, breakthroughs in immunotherapy, and methods for microenvironment manipulation.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Major Drivers Are Impacting The Cell Therapy Market?

The increasing occurrence of chronic illnesses supported the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a long-term condition, lasting a year or longer, that necessitates medical care, restricts daily life, or both, encompassing conditions such as heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells offer potential advantages for individuals affected by spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency in the US, published notable updates concerning public health programs. Annually, more than 944,800 Americans succumb to heart disease or stroke, representing over one-third of all fatalities. Each year in the U.S., 1.7 million individuals receive a cancer diagnosis, resulting in over 600,000 deaths, positioning it as the second leading cause of death. Furthermore, over 38 million Americans live with diabetes, and an additional 98 million adults are prediabetic, elevating their susceptibility to type 2 diabetes. Diabetes carries the potential for serious complications such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, thereby increasing the likelihood of chronic conditions like type 2 diabetes, heart disease, and specific cancers. The increasing incidence of chronic diseases has boosted the demand for cell therapies and fostered the expansion of the cell therapy market.

Which Segment Categories Are Driving Maximum Growth In The Cell Therapy Market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Which Long-Term Trends Will Play A Crucial Role In The Cell Therapy Market?

Leading market entities are forming strategic alliances and collaborations to broaden their product range and extend their global footprint. In November 2023, Ajinomoto Co Inc., a food company headquartered in Japan, completed the acquisition of Forge Biologics for $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.’s worldwide proficiency in AAV and plasmid gene therapy manufacturing, thereby enriching and reinforcing its current contract development and manufacturing services. Forge Biologics is a US-based biotechnology enterprise dedicated to advancing cell therapy technologies for the treatment of diverse illnesses.

Who Are The Dominant Players In The Cell Therapy Market Today?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Region Is At The Forefront Of Innovation In The Cell Therapy Market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2025, By The Business Research Company

Flow Cytometry Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795